<DOC>
	<DOCNO>NCT02830360</DOCNO>
	<brief_summary>This pilot study determine feasibility large scale multicenter trial compare first line catheter ablation antiarrhythmic drug therapy patient prior MI , ICD VT .</brief_summary>
	<brief_title>Antiarrhythmics Ablation Ventricular Tachycardia Pilot</brief_title>
	<detailed_description>This multicentre , parallel group , two arm , unblinded vanguard pilot randomize clinical trial . A vanguard pilot study design choose order prove feasibility without commit full trial feasibility demonstrate . Implantable Defibrillators ( ICDs ) reduce sudden death terminate VT without shock , n't prevent VT ; appropriate strategy suppress VT remain unknown . The widespread use ICDs mean patient formerly would suffer sudden death survive , may experience recurrent VT ICD therapy . Therapeutic option VT limit . Appropriate ICD program reduces unnecessary shock , VT may still recur require therapy . VANISH 2 assess outcome patient prior MI VT randomize catheter ablation antiarrhythmic drug therapy .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<mesh_term>Sotalol</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<criteria>Prior Myocardial Infarction One follow VT event treat amiodarone , sotalol , another class I class III antiarrhythmic drug ) within last 6 month : Sustained monomorphic VT document 12lead ECG rhythm strip terminate pharmacologic mean DC cardioversion ≥3 episodes VT treat antitachycardia pacing ( ATP ) , least one symptomatic ≥ 5 episode VT treat antitachycardia pacing ( ATP ) regardless symptoms ≥1 appropriate ICD shock , ≥3 VT episodes within 24 hour Unable unwilling provide inform consent . Active ischemia ( acute thrombus diagnose coronary angiography , dynamic ST segment change demonstrate ECG ) another reversible cause VT ( e.g . druginduced arrhythmia ) , recent acute coronary syndrome within 30 day , coronary revascularization ( &lt; 90 day bypass surgery , &lt; 30 day percutaneous coronary intervention ) , CCS functional class IV angina . Note biomarker level elevation alone ventricular arrhythmias denote acute coronary syndrome active ischemia . Are ineligible sotalol ( base upon criterion list section 3.2.1 know intolerance/allergy ) , amiodarone ( e.g . due active hepatitis , current hyperthyroidism , pulmonary fibrosis , know allergy ) . Are know protrude left ventricular thrombus mechanical aortic mitral valve Have prior catheter ablation procedure VT Are renal failure ( Creatinine clearance &lt; 15 mL/min ) , NYHA Functional class IV heart failure , systemic illness likely limit survival &lt; 1 year Have recent ST elevation myocardial infarction nonST elevation MI ( &lt; 30 day ) ; note biomarker elevation alone ventricular arrhythmias denote MI . Are pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Antiarrhythmic drug therapy</keyword>
	<keyword>VT Catheter ablation</keyword>
	<keyword>ICD Therapy</keyword>
	<keyword>Ischemic Heart Disease</keyword>
</DOC>